A detailed history of Asset Dedication, LLC transactions in Viatris Inc stock. As of the latest transaction made, Asset Dedication, LLC holds 1,467 shares of VTRS stock, worth $17,339. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,467
Previous 1,618 9.33%
Holding current value
$17,339
Previous $12,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$10.05 - $12.02 $1,517 - $1,815
-151 Reduced 9.33%
1,467 $15,000
Q1 2024

Apr 16, 2024

SELL
$11.27 - $13.53 $191 - $230
-17 Reduced 1.04%
1,618 $12,000
Q4 2023

Feb 08, 2024

SELL
$8.77 - $10.85 $184 - $227
-21 Reduced 1.27%
1,635 $12,000
Q3 2023

Nov 13, 2023

SELL
$9.59 - $11.35 $671 - $794
-70 Reduced 4.06%
1,656 $11,000
Q2 2023

Aug 21, 2023

BUY
$9.02 - $10.29 $72 - $82
8 Added 0.47%
1,726 $11,000
Q1 2023

Apr 21, 2023

SELL
$9.2 - $12.26 $505 - $674
-55 Reduced 3.1%
1,718 $11,000
Q4 2022

Jan 19, 2023

BUY
$8.72 - $11.56 $497 - $658
57 Added 3.32%
1,773 $13,000
Q3 2022

Oct 27, 2022

SELL
$8.48 - $11.13 $1,958 - $2,571
-231 Reduced 11.86%
1,716 $8,000
Q2 2022

Jul 19, 2022

SELL
$9.95 - $12.27 $1,054 - $1,300
-106 Reduced 5.16%
1,947 $13,000
Q1 2022

Apr 21, 2022

SELL
$9.81 - $15.4 $6,033 - $9,471
-615 Reduced 23.05%
2,053 $15,000
Q4 2021

Jan 21, 2022

SELL
$12.09 - $14.68 $11,304 - $13,725
-935 Reduced 25.95%
2,668 $29,000
Q3 2021

Oct 18, 2021

BUY
$13.25 - $15.13 $3,975 - $4,539
300 Added 9.08%
3,603 $40,000
Q2 2021

Jul 21, 2021

BUY
$12.97 - $16.15 $4,526 - $5,636
349 Added 11.81%
3,303 $38,000
Q1 2021

May 03, 2021

SELL
$13.59 - $18.54 $29,150 - $39,768
-2,145 Reduced 42.07%
2,954 $36,000
Q4 2020

Jan 28, 2021

BUY
$14.3 - $18.74 $72,915 - $95,555
5,099 New
5,099 $62,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.3B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Asset Dedication, LLC Portfolio

Follow Asset Dedication, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Dedication, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asset Dedication, LLC with notifications on news.